Skip to main content
SpringerLink
Log in

The response of the normochromic normocytic anaemia of chronic renal failure to Desferrioxamine

  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Summary

Five patients with chronic renal failure on haemodialysis with the normochromic normocytic anaemia of chronic renal failure, were treated with Desferrioxamine 40 mgs/Kg/week, over a period of three months for aluminium osteodystrophy. The mean haemoglobin rise was 2.5±0.3 grams% (P< 0.05). The haematocrit rose by 9±2.5% (P< 0.05). The mean ±s.e.m. M.C.V. rise was 5±0.85 Fl (P< 0.001) and the mean ±s.e.m. M.C.H. rise was 2.5±0.28 (P< 0.001). The red blood cell and M.C.H.C. did not show a significant rise. Serum Ferritin levels were raised with a mean of 1500±350 and fell by 500±150 (P< 0.001). The transfusion requirement of the five patients (previously 10 units per month) fell to 2 units per month over the same period. The renal indices did not show a significant change.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Elliott, H. L., Dryburgh, F., Fell, G. S. et al. Aluminium toxicity during regular haemodialysis. Br. Med. J. 1978: 1101–1103.

  2. O’Hare, J. A., Murnaghan, D. J. Reversal of aluminium-induced haemodialysis anaemia by low-aluminium dialysate. N. Engl. J. Med. 1982: 306, 654–656.

    PubMed  CAS  Google Scholar 

  3. Kaiser, L., Schwartz, K. A., Burnatowska Hledin, M. A. et al. Microcytic anaemia secondary to intraperitoneal aluminium in normal and uraemic rats. Kidney Int. 1986: 26, 269–274.

    Article  Google Scholar 

  4. Meredith, P. A., Moore, M. R., Goldbert, A. The effects of aluminium, lead and zinc on delta-amino laevulinic acid dehydratase. Biochem. Soc. Trans. 1974: 1243–1245.

  5. Praga, M., Andres, A., Nieto, J. et al. Desferrioxamine (DFO) improves the anaemia of haemodialysis patients without aluminium (AL) intoxication. Proc. EDTA 1986: 23, 64 (abstract).

    Google Scholar 

  6. Tielemans, C., Collart, F., Wens, R. et al. Improvement of anaemia with deferoxamine in haemodialysis patients with aluminium-induced bone disease. Clin. Nephrol. 1985: 24, 237–241.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Medicine, Meath Hospital, Heytesbury Street, Dublin 8

    A. A. J. O’Brien, D. P. Moore & J. A. B. Keogh

Authors
  1. A. A. J. O’Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. P. Moore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. A. B. Keogh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Brien, A.A.J., Moore, D.P. & Keogh, J.A.B. The response of the normochromic normocytic anaemia of chronic renal failure to Desferrioxamine. I.J.M.S. 156, 236–237 (1987). https://doi.org/10.1007/BF02954052

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02954052

Keywords

Search

Navigation